We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking NGNE? Get live short interest, options flow, and signals on ORTEX.Sign up free →
NG

Neurogene Inc. (NGNE) short interest & options flow

NASDAQ

Neurogene Inc. heads into the week after its August 12 earnings release with analyst targets scattered across a wide range and short interest entrenched near a fifth of the free float. The analyst reaction to earnings landed within hours of the results. Canaccord Genuity's Whitney Ijem kept her Buy rating but trimmed the target from $180 to $166. Guggenheim moved the other way…

$26.00+2.73% 1d-2.29% 1w-1.52% 1mClose: 9 Nov 2026
Short interest % of float
High
Live SI on ORTEX →
Cost to borrow
Low
Live CTB on ORTEX →
Market cap
$520M
Next earnings
10 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 10 Nov 2026

ORTEX chart of Neurogene Inc. (NGNE) share price and short interest (% of free float), six months to November 9, 2026

NGNE news and analysis

RSS

No long-form analysis yet for NGNE. Pulse alerts and the live data picture are available on ORTEX.

Open NGNE on ORTEX →

Want the live picture for NGNE?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NGNE — free to start on ORTEX.

Sign up for free →Open NGNE on ORTEX